Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
NCT ID: NCT01992094
Last Updated: 2015-12-10
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
2680 participants
INTERVENTIONAL
2013-11-30
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
QIVc
Influenza vaccine
QIVc
Novartis Investigational Quadrivalent Vaccine
TIV1c
Influenza vaccine
TIV1c
Licensed Influenza Vaccine
TIV2c
Influenza vaccine
TIV2c
Novartis Investigational Vaccine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
QIVc
Novartis Investigational Quadrivalent Vaccine
TIV1c
Licensed Influenza Vaccine
TIV2c
Novartis Investigational Vaccine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Individuals who give written informed consent, who can comply with study procedures, and who are available for follow-up.
Exclusion Criteria
2. Subjects with contraindications to receive influenza vaccine
3. Please contact the site for additional eligibility criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis Vaccines
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Novartis Vaccines
Role: STUDY_CHAIR
Novartis Vaccines
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Huntsville, Alabama, United States
Phoenix, Arizona, United States
Anaheim, California, United States
San Diego, California, United States
Coral Gables, Florida, United States
Hollywood, Florida, United States
Melbourne, Florida, United States
South Miami, Florida, United States
West Palm Beach, Florida, United States
Peoria, Illinois, United States
Mishawaka, Indiana, United States
Council Bluffs, Iowa, United States
Newton, Kansas, United States
Wichita, Kansas, United States
Wichita, Kansas, United States
Metairie, Louisiana, United States
Rockville, Maryland, United States
Edina, Minnesota, United States
Bellevue, Nebraska, United States
Omaha, Nebraska, United States
Endwell, New York, United States
Rochester, New York, United States
Cary, North Carolina, United States
Charlotte, North Carolina, United States
Raleigh, North Carolina, United States
Wilmington, North Carolina, United States
Oklahoma City, Oklahoma, United States
Warwick, Rhode Island, United States
Anderson, South Carolina, United States
Mt. Pleasant, South Carolina, United States
Dakota Dunes, South Dakota, United States
Austin, Texas, United States
Austin, Texas, United States
Dallas, Texas, United States
Fort Worth, Texas, United States
San Angelo, Texas, United States
Salt Lake City, Utah, United States
Salt Lake City, Utah, United States
Salt Lake City, Utah, United States
South Jordan, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
V130_01
Identifier Type: -
Identifier Source: org_study_id